BIO-TECHNE Corp Goodwill
BIO-TECHNE Corp (TECH) had Goodwill of $975.36 million as of 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-24
- 2026-06-30: Goodwill $975.36M.
- 2026-03-31: Goodwill $977.80M.
- 2025-12-31: Goodwill $980.56M.
- 2025-09-30: Goodwill $978.91M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2026-06-30 | $975.36M 10-K · filed 2026-08-24 | |
| 2026-03-31 | $977.80M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $980.56M 10-Q · filed 2026-02-04 | |
| 2025-09-30 | $978.91M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $980.93M 10-K · filed 2026-08-24 | |
| 2025-03-31 | $968.61M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $964.61M 10-Q · filed 2025-02-06 | |
| 2024-09-30 | $982.59M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $972.66M 10-K · filed 2026-08-24 | |
| 2024-03-31 | $970.97M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $980.08M 10-Q · filed 2024-02-07 | |
| 2023-09-30 | $969.38M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $872.74M 10-K · filed 2025-08-22 | |
| 2023-03-31 | $870.54M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $869.59M 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $865.42M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $822.10M 10-K · filed 2024-08-22 | |
| 2022-03-31 | $827.62M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $832.06M 10-Q · filed 2022-02-07 | |
| 2021-09-30 | $843.07M 10-Q · filed 2022-02-07 | $840.02M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $843.07M 10-K · filed 2023-08-23 | |
| 2021-03-31 | $746.46M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $728.31M 10-Q · filed 2021-05-07 | $746.67M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $731.64M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $728.31M 10-K · filed 2022-08-24 | $728.31M 10-K · filed 2020-08-26 |
| 2020-03-31 | $725.83M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $734.24M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $730.41M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $732.67M 10-K · filed 2021-08-25 | |
| 2019-03-31 | $719.61M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $706.36M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $704.79M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $597.89M 10-K · filed 2020-08-26 | |
| 2018-03-31 | $610.67M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $589.10M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $587.78M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $579.03M 10-K/A · filed 2019-11-06 | |
| 2017-03-31 | $569.74M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $557.73M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $565.79M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $430.88M 10-K · filed 2018-08-27 | |
| 2016-03-31 | $434.73M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $423.89M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $427.32M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $390.64M 10-K · filed 2017-09-07 | |
| 2015-03-31 | $385.83M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $401.65M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $305.23M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $151.47M 10-K · filed 2016-08-29 | |
| 2014-03-31 | $144.65M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $144.36M 10-Q · filed 2014-02-04 | |
| 2013-09-30 | $143.80M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $84.34M 10-K · filed 2015-08-31 | |
| 2013-03-31 | $84.31M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $87.17M 10-Q · filed 2013-02-11 | |
| 2012-09-30 | $86.94M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $85.68M 10-K · filed 2014-08-29 | |
| 2012-03-31 | $86.52M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $85.24M 10-Q · filed 2012-02-07 | |
| 2011-09-30 | $85.36M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $86.63M 10-K · filed 2013-08-29 | |
| 2011-03-31 | $25.07M 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $25.07M 10-Q · filed 2011-02-09 | |
| 2010-09-30 | $25.07M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $25.07M 10-K · filed 2012-08-29 | |
| 2009-06-30 | $25.07M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |